Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease

By Torralba M.   Pérez-Calvo J.  

Journal of Inherited Metabolic Disease, Vol. 32, Iss. 3, 2009-06 ,pp. : 453-454

Springer Publishing Company

Access to resources Recommend Favorite

Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses

By Cox T.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 107-123

Springer Publishing Company

Access to resources Recommend Favorite

Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements

By Grabowski Gregory   Andria Generoso   Baldellou Antonio   Campbell Pauline   Charrow Joel   Cohen Ian   Harris Chris   Kaplan Paige   Mengel Eugen   Pocovi Miguel   Vellodi Ashok  

European Journal of Pediatrics, Vol. 163, Iss. 2, 2004-02 ,pp. : 58-66

Springer Publishing Company

Access to resources Recommend Favorite

Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry

By Tylki-Szymańska Anna   Vellodi Ashok   El-Beshlawy Amal   Cole J.   Kolodny Edwin  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 4, 2010-08 ,pp. : 339-346

Springer Publishing Company

Access to resources Recommend Favorite

Clinical response to sildenafil in pulmonary hypertension associated with Gaucher disease

By Fernandes C.   Jardim C.   Carvalho L.   Farias A.   Filho M.   Souza R.  

Journal of Inherited Metabolic Disease, Vol. 28, Iss. 4, 2005-06 ,pp. : 603-605

Springer Publishing Company

Access to resources Recommend Favorite